F11

F11 company information, Employees & Contact Information

Explore related pages

Related company profiles:

We are a leading technology company offering advertisers, agencies and small and medium businesses (via resellers) the most intuitive one-stop-platform for digital advertising on the market. With our powerful digital media products, we are a true alternative to Google and Facebook on the Open Internet. Currently, our platform supports the media channels Display, Mobile, Video and Digital Out of Home. CTV will follow soon!

Company Details

Employees
147
Founded
-
Address
Watzenborner Weg 4, Gießen,hessen 35394,germany
Phone
+49 641 460 92 - 0
Email
in****@****even.de
Industry
Advertising Services
NAICS
Marketing Consulting Services
HQ
Gießen, Hessen
Looking for a particular F11 employee's phone or email?

F11 Questions

News

Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism - Nature

Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism Nature

Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI - The New England Journal of Medicine

Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI The New England Journal of Medicine

Inhibition of Factor XI Using RBD4059: A Novel GalNAc-siRNA With Potent and Durable Antithrombotic Effects - ScienceDirect.com

Inhibition of Factor XI Using RBD4059: A Novel GalNAc-siRNA With Potent and Durable Antithrombotic Effects ScienceDirect.com

Unlocking digital advertising for every business. - GP Bullhound

Unlocking digital advertising for every business. GP Bullhound

Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI - The New England Journal of Medicine

Uncoupling Thrombosis and Hemostasis by Inhibiting Factor XI The New England Journal of Medicine

Factor XI Deficiency: Practice Essentials, Background, Pathophysiology - Medscape eMedicine

Factor XI Deficiency: Practice Essentials, Background, Pathophysiology Medscape eMedicine

Marvel Comics Cancels X-Force, NYX And Probably X-Factor With #10 - Bleeding Cool News

Marvel Comics Cancels X-Force, NYX And Probably X-Factor With #10 Bleeding Cool News

Genetically Determined FXI (Factor XI) Levels and Risk of Stroke - American Heart Association Journals

Genetically Determined FXI (Factor XI) Levels and Risk of Stroke American Heart Association Journals

Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure - Science | AAAS

Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure Science | AAAS

Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI - PNAS

Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI PNAS

Factor XI Inhibition: The Holy Grail of Haemostasis-Sparing Anticoagulation - European Medical Journal

Factor XI Inhibition: The Holy Grail of Haemostasis-Sparing Anticoagulation European Medical Journal

Growth differentiation factor 11 delivered by dairy Lactococcus lactis strains modulates inflammation and prevents mucosal damage in a mice model of intestinal mucositis - Frontiers

Growth differentiation factor 11 delivered by dairy Lactococcus lactis strains modulates inflammation and prevents mucosal damage in a mice model of intestinal mucositis Frontiers

Milvexian: An Oral, Bioavailable Factor XIa Inhibitor - SpringerMedizin.de

Milvexian: An Oral, Bioavailable Factor XIa Inhibitor SpringerMedizin.de

Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice | Scientific Reports - Nature

Growth Differentiation Factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice | Scientific Reports Nature

Abelacimab for Prevention of Venous Thromboembolism - The New England Journal of Medicine

Abelacimab for Prevention of Venous Thromboembolism The New England Journal of Medicine

Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial - Nature

Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial Nature

Asundexian versus Apixaban in Patients with Atrial Fibrillation - The New England Journal of Medicine

Asundexian versus Apixaban in Patients with Atrial Fibrillation The New England Journal of Medicine

A single-domain antibody targeting factor XII inhibits both thrombosis and inflammation - Nature

A single-domain antibody targeting factor XII inhibits both thrombosis and inflammation Nature

Milvexian for the Prevention of Venous Thromboembolism - The New England Journal of Medicine

Milvexian for the Prevention of Venous Thromboembolism The New England Journal of Medicine

High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis - The New England Journal of Medicine

High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis The New England Journal of Medicine

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint - Frontiers

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint Frontiers

TET (Ten-eleven translocation) family proteins: structure, biological functions and applications - Nature

TET (Ten-eleven translocation) family proteins: structure, biological functions and applications Nature

How technology and the world have changed since 9/11 - Brookings

How technology and the world have changed since 9/11 Brookings

X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua) - The New England Journal of Medicine

X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua) The New England Journal of Medicine

Predictive design of sigma factor-specific promoters - Nature

Predictive design of sigma factor-specific promoters Nature

Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 - The Lancet

Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 The Lancet

Welcome to the World Journal of Gastroenterology - Baishideng Publishing Group

Welcome to the World Journal of Gastroenterology Baishideng Publishing Group

Factor XI Deficiency in Ashkenazi Jews in Israel - The New England Journal of Medicine

Factor XI Deficiency in Ashkenazi Jews in Israel The New England Journal of Medicine

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant